With the region experiencing yet another surge in cases of COVID-19, the Mobile Integrated Health (MIH) program is participating in an innovative clinical trial that brings a much talked about drug to treat COVID-19 (remdesivir) to patients at home, instead of at the hospital.

South Shore Hospital, part of South Shore Health, has received an Innovator Award from the editors of Healthcare Innovation for its groundbreaking work in Clinical Pharmacy Practice by improving the medication reconciliation process.

In late 2022, the White House, in partnership with the National Security Council, issued a national Request for Information (RFI) on clinical research infrastructure and emergency clinical trials. The aim of the request is to obtain information from a wide range of clinical trial stakeholders to...

South Shore Health’s Nurse Residency Program has earned Practice Transition Accreditation Program® (PTAP) accreditation from the American Nurses Credentialing Center (ANCC). This designation - the highest level awarded by the ANCC - recognizes organizations that demonstrate excellence in preparing new nurses for successful transition into practice.

In May 2021, South Shore Hospital, part of South Shore Health, partnered with Boston Children’s Hospital on a new COVID-19 clinical trial. Patients admitted to the intensive care unit with severe COVID-19 pneumonia who require mechanical ventilation are invited to participate in this study. The...

South Shore Health is accepting applications for the PGY-1 Pharmacy Residency Program, the health system announced. The program is a full-year, integrated learning experience to prepare pharmacists for a future in clinical pharmacy.

After an unannounced and extensive site visit, Massachusetts Department of Public Health (DPH) surveyors certified the South Shore VNA as being in compliance with all regulatory requirements and without any deficiencies, meaning in essence they earned a perfect review.